[144] Surgery Partners, Inc. SEC Filing

Rhea-AI Filing Summary

Rule 144 notice filed for Surgery Partners, Inc. (SGRY) reporting a proposed sale of 25,000 common shares via UBS Financial Services on 08/26/2025 at an aggregate market value of $572,500. The shares were acquired on 08/26/2025 through an equity option exercise from Surgery Partners, Inc. The filer also disclosed a prior sale by Wayne DeVeydt of 100,000 common shares on 08/21/2025 for gross proceeds of $2,299,011. The notice includes the required representation that the seller is not aware of any undisclosed material adverse information about the issuer.

Positive

• Disclosure transparency: The filer provided required Rule 144 details including acquisition method, broker, sale date, and aggregate market value.
• Attestation included: The seller attests to not possessing undisclosed material adverse information, fulfilling a key representation on the form.

Negative

• Insider selling activity: A planned sale of 25,000 shares and a recent sale of 100,000 shares may indicate insider liquidity rather than long-term holding.
• Concentration of recent sales: The 100,000-share sale on 08/21/2025 produced $2,299,011, a sizable disposition disclosed within the same filing set.

Insights

Securities Analyst

TL;DR: Insider exercises options and plans a modest Rule 144 sale; prior large sale by Wayne DeVeydt noted.

The filing shows an insider acquired 25,000 shares via equity option exercise and intends to sell those shares under Rule 144 through UBS on 08/26/2025, with an indicated aggregate market value of $572,500. A separate recent sale by Wayne DeVeydt of 100,000 shares generated $2,299,011 in gross proceeds on 08/21/2025. These disclosures are routine for officers or insiders monetizing equity awards and provide transparency on share disposition timing and magnitude.

Corporate Governance Expert

TL;DR: The filing complies with Rule 144 disclosure requirements but shows insider selling activity.

The notice documents acquisition by exercise and planned resale under Rule 144, including the seller's attestation regarding material non-public information. The combination of a new exercise-and-sell transaction and a recent 100,000-share sale by an identified individual suggests active insider liquidity but does not in itself indicate governance concerns; it does, however, warrant disclosure monitoring for patterns of insider sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	25000	572500	128209410	08/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/26/2025	Equity Compensation	Surgery Partners, Inc.			25000	08/26/2025	Equity Option Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/21/2025	100000	2299011

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Surgery Partners (SGRY) disclose?

The Form 144 shows a proposed sale of 25,000 common shares via UBS on 08/26/2025 (aggregate market value $572,500), acquired by equity option exercise on 08/26/2025.

Who sold shares recently according to this filing?

The filing lists a sale by Wayne DeVeydt of 100,000 common shares on 08/21/2025 for gross proceeds of $2,299,011.

Through which broker will the 25,000 SGRY shares be sold?

The planned sale of 25,000 common shares is through UBS Financial Services Inc, 1000 Harbor Blvd, Weehawken, NJ.

How were the 25,000 shares acquired?

The 25,000 shares were acquired on 08/26/2025 via an equity option exercise from Surgery Partners, Inc.

Does the filer state any undisclosed material information?

The signer represents that they do not know of any material adverse information about the issuer that has not been publicly disclosed.